Academic Journal
Q1Diabetes Technology and Therapeutics
About Diabetes Technology and Therapeutics
Diabetes Technology and Therapeutics is a scholarly journal published by Mary Ann Liebert Inc.. SCImago 2025 lists it in Q1, with an SJR of 2.663 and H-index of 116.
Coverage: 1999-2026. Research categories: Endocrinology (Q1); Endocrinology, Diabetes and Metabolism (Q1); Medical Laboratory Technology (Q1); Medicine (miscellaneous) (Q1).
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
Scope information will be added after verification.
Recent Research Articles
Latest publications matched automatically by ISSN.
Sustained Glycemic Outcomes with the MiniMed ™ 780G System: Real-World Evidence from >16,000 Users Across 18 Latin American Countries Over Two Years
Matias Castro, Bruno Grassi, Alejandro Daín, Ana María Gómez et al.
2026-09-19 · DOI: 10.1177/15209156261486558Association Between Continuous Glucose Monitoring Utilization and Glucagon-Like Peptide-1 Receptor Agonist Discontinuation in Type 2 Diabetes: A Real-World Study
Eugene E. Wright, Eileen Huang, Anila Bindal
2026-09-19 · DOI: 10.1177/15209156261489904Use of Continuous Glucose Monitoring Indicators to Guide Dose Titration of Weekly Basal Insulin Efsitora Alfa in Insulin-Naive and Basal Insulin-Experienced Adults with Type 2 Diabetes: A Retrospective Analyis
Richard M. Bergenstal, Michael B. Davidson, David Ahn, Grazia Aleppo et al.
2026-09-17 · DOI: 10.1177/15209156261485755Continuous Glucose Monitoring Hypoglycemia Alarms in Critical Care: Clinical Utility and Workflow Integration
Eileen R. Faulds, Melanie Natasha Rayan, Emily S. Patterson, Molly McNett et al.
2026-09-16 · DOI: 10.1177/15209156261487821Long-Term Clinical and Economic Impact of Automated Insulin Delivery Systems Use in Pediatric and Adolescents Type 1 Diabetes: Results Across Australia, Canada, the UK, and the USA
Laurent Legault, Jennifer L. Sherr, Elizabeth A. Davis, Mónica Cerezales et al.
2026-09-10 · DOI: 10.1177/15209156261486122Pediatric Inpatient Continuous Glucose Monitor Accuracy by Sensor Wear Day, Hospital Day, and Glucose Rate of Change
Jessica L. Ruiz, Amy B. Stein, Alexander Wheelock, Bennett Stewart et al.
2026-09-10 · DOI: 10.1177/15209156261486139Real-World Data from U.S. Commercial Users of the 365-Day Implantable Eversense Continuous Glucose Monitoring System, Including with the Twiist Automated Insulin Delivery System Integration
Francine Kaufman, Ishaan Jain, Shaoling Han, Colleen Mdingi et al.
2026-09-08 · DOI: 10.1177/15209156261486125Adjunctive Treatments for Patients with Type 1 Diabetes Using Automated Insulin Delivery Systems. A Narrative Review
Konstantinos Kitsios, Christina-Maria Trakatelli
2026-09-04 · DOI: 10.1177/15209156261486127Optimizing Continuous Glucose Monitoring for Older Adults with Diabetes: From Clinical Evidence to a Practical Implementation Pathway
Tong Yang, Jinghao Cai, Jiaying Ni, Jingyi Lu et al.
2026-09-03 · DOI: 10.1177/15209156261485635Real-Time Continuous Glucose Monitoring Improves Glycemic Control in the Early Postoperative Period Following Liver Transplantation: A Randomized Controlled Trial
Marek Protus, Barbora Voglova Hagerf, Antonin Jabor, Janka Franekova et al.
2026-08-24 · DOI: 10.1177/15209156261480872Natural History of Mild Non-Proliferative Diabetic Retinopathy in Adults with Type 1 Diabetes Under Contemporary Diabetes Care
Ana Piñar-Gutiérrez, José María Madruga-Rubio, Noelia Gros-Herguido, Sandra Amuedo et al.
2026-08-21 · DOI: 10.1177/15209156261481005Determinants of Continuous Glucose Monitoring Accuracy in Critically Ill Patients Requiring Mechanical Ventilation and Vasopressor Support
Ola Friman, Samuel Wiqvist, Marcus Lind, Pia Zetterqvist et al.
2026-08-20 · DOI: 10.1177/15209156261479816Letter: Authors’ Response to LTE by Scaramuzza et al.
Maya Laron-Hirsh, Sapir Barel, Anirban Roy, George Mallas et al.
2026-08-20 · DOI: 10.1177/15209156261481250Letter: Impact of Sensor Technical Specifications on Automated Insulin Delivery Performance: Does the Sensor Really not Matter?
Andrea E. Scaramuzza, Riccardo Bonfanti, Enza Mozzillo, Riccardo Schiaffini et al.
2026-08-19 · DOI: 10.1177/15209156261481237Continuous Glucose Monitoring and Automated Insulin Delivery in Infants with Type 1 Diabetes: Real-World Evidence to Support Future International Guidelines
Marco Marigliano, Andrea E. Scaramuzza, Claudia Arnaldi, Riccardo Bonfanti et al.
2026-08-18 · DOI: 10.1177/15209156261479814CGM Metrics and the Risk of Pregnancy Complications in Type 1 Diabetes: A Secondary Exploratory Analysis of the CRISTAL Trial
Ina Geerts, Kaat Beunen, Liese Berger, Nancy Van Wilder et al.
2026-08-12 · DOI: 10.1177/15209156261477154Automated Insulin Delivery System Initiation Safely Improves Glycemic Outcomes in Older Adults with Type 1 Diabetes
Carmen Quirós, Montserrat Granados, María J. Picón, Lía Nattero-Chávez et al.
2026-08-03 · DOI: 10.1177/15209156261474587Ensuring Equitable Access to Diabetes Technology for People with Disabilities
Rohan Maini, Rozalina G. McCoy, Grenye O’Malley, Carol J. Levy et al.
2026-07-31 · DOI: 10.1177/15209156261473328Perioperative Blood Glucose Control following Implementation of Standardized Protocols in Children and Adolescents with Diabetes Undergoing Surgery
Abdulrahman Habib, Nour Almoutairi, Evangelia Elenakis, Anne Marie Sbrocchi et al.
2026-07-30 · DOI: 10.1177/15209156261476377Continuous Glucose Monitoring Metrics in Women with Type 2 Diabetes in Pregnancy: The TIMELY Observational Cohort Study
Denice S. Feig, Jennifer M. Yamamoto, Afshan Zahedi, Eleanor M. Scott et al.
2026-07-21 · DOI: 10.1177/15209156261470491Reviews
Community Reviews
Version History
September 18, 2026 at 2:15 am
September 18, 2026